What is the best treatment option after progression to chemotherapy/immunotherapy (chemo/IO) as first-line treatment for PD-L1–positive lung adenocarcinoma with no sensitizing mutations?
Bruno Saldivar-Oviedo
Advertisement
Articles by Bruno Saldivar-Oviedo
Advertisement
Latest Updated Articles
What Are Treatment Options After Progression in PDL-1–Positive Metastatic Lung Adenocarcinoma after Chemo/IO?Published: August 23rd 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
More Global Expertise and Talent Are Needed to Administer Cell Therapies
2
FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset
3
Examining the Full Scope of Future Advancements in Radiation Oncology
4
Adaptive Treatment and Other Advances May Drive Radiotherapy Field Forward
5
